{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:01Z","timestamp":1786991221518,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jaad.2019.04.029","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T10:50:42Z","timestamp":1555671042000},"page":"355-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Nonbullous pemphigoid: Insights in clinical and diagnostic findings, treatment responses, and prognosis"],"prefix":"10.1016","volume":"81","author":[{"given":"Aniek","family":"Lamberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendri H.","family":"Pas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles F.H.","family":"Diercks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel F.","family":"Jonkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9863","key":"10.1016\/j.jaad.2019.04.029_bib1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2019.04.029_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"10.1016\/j.jaad.2019.04.029_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","article-title":"Comorbidity profiles among\u00a0patients with bullous pemphigoid: a nationwide population-based study","volume":"165","author":"Chen","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.04.029_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep37125","article-title":"Psychiatric and\u00a0neurological disorders are associated with bullous pemphigoid\u2013a nationwide Finnish Care Register study","volume":"6","author":"F\u00f6rsti","year":"2016","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.jaad.2019.04.029_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00403-017-1772-x","article-title":"Mortality in bullous pemphigoid and prognostic factors in 1st and 3rd year of follow-up in specialized centre in Poland","volume":"309","author":"Kalinska-Bienias","year":"2017","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.jaad.2019.04.029_bib6","first-page":"72","article-title":"Mortality in patients with bullous pemphigoid: a retrospective cohort study, systematic review and meta-analysis","volume":"99","author":"Kridin","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.029_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/jamadermatol.2018.4390","article-title":"Assessment of diagnostic strategy for early recognition of bullous and nonbullous variants of pemphigoid","volume":"155","author":"Meijer","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.04.029_bib8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaad.2017.10.035","article-title":"Nonbullous pemphigoid: a systematic review","volume":"78","author":"Lamberts","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2019.04.029_bib9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamadermatol.2013.756","article-title":"Bullous pemphigoid as pruritus in the elderly: a common presentation","volume":"149","author":"Bakker","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.04.029_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-4632.2004.02457.x","article-title":"Prodromal bullous pemphigoid","volume":"45","author":"Lamb","year":"2006","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.04.029_bib11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","article-title":"Atypical\u00a0presentations of bullous pemphigoid: clinical and\u00a0immunopathological aspects","volume":"14","author":"Cozzani","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.jaad.2019.04.029_bib12","first-page":"508","article-title":"Bullous pemphigoid presenting as generalized pruritus: observations in six patients","volume":"37","author":"Alonso-Llamazares","year":"1998","journal-title":"Int J Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2019.04.029_bib13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/1346-8138.13782","article-title":"Non-bullous lesions as the first manifestation of bullous pemphigoid: a retrospective analysis of 181 cases","volume":"44","author":"Zhang","year":"2017","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.04.029_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/09546630802683876","article-title":"Non-bullous lesions as the first manifestation of bullous pemphigoid: a retrospective analysis of 24 cases","volume":"20","author":"Sun","year":"2009","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jaad.2019.04.029_bib15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology","volume":"172","author":"Feliciani","year":"2015","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.04.029_bib16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.04.029_bib17","series-title":"Statistics with\u00a0Confidence","author":"Altman","year":"2000"},{"issue":"5","key":"10.1016\/j.jaad.2019.04.029_bib18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2133.2012.11108.x","article-title":"Clinical presentation and diagnostic delay in bullous pemphigoid: a\u00a0prospective nationwide cohort","volume":"167","author":"Della Torre","year":"2012","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2019.04.029_bib19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cup.13343","article-title":"The spectrum of histopathologic findings in pemphigoid: avoiding diagnostic pitfalls","volume":"45","author":"Hodge","year":"2018","journal-title":"J Cutan Pathol"},{"issue":"7","key":"10.1016\/j.jaad.2019.04.029_bib20","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid","volume":"72","author":"de Graauw","year":"2017","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.jaad.2019.04.029_bib21","doi-asserted-by":"crossref","first-page":"e107725","DOI":"10.1371\/journal.pone.0107725","article-title":"Human eosinophils express the high affinity IgE receptor, Fc\u03b5RI, in bullous pemphigoid","volume":"9","author":"Messingham","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.029_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1523-1747.ep12259692","article-title":"Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin","volume":"82","author":"Gammon","year":"1984","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.04.029_bib23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2013.07.009","article-title":"Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid","volume":"69","author":"Sardy","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.029_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1684\/ejd.2015.2719","article-title":"Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins","volume":"26","author":"Hayakawa","year":"2016","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.04.029_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0625.2009.00948.x","article-title":"Animal models for autoimmune bullous dermatoses","volume":"19","author":"Bieber","year":"2010","journal-title":"Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.04.029_bib26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.humimm.2014.01.005","article-title":"IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice","volume":"75","author":"Feldrihan","year":"2014","journal-title":"Hum Immunol"},{"issue":"6","key":"10.1016\/j.jaad.2019.04.029_bib27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0625.1995.tb00062.x","article-title":"Bullous pemphigoid: serum antibody titre and antigen specificity","volume":"4","author":"Pas","year":"1995","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.04.029_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1523-1747.ep12358276","article-title":"Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid","volume":"101","author":"Hall","year":"1993","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.04.029_bib29","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.jaad.2019.04.029_bib30","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"10079","key":"10.1016\/j.jaad.2019.04.029_bib31","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0140-6736(17)30560-3","article-title":"Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial","volume":"389","author":"Williams","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.029_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2019.04.029_bib33","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219306206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219306206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:50:45Z","timestamp":1759272645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219306206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0190962219306206"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.04.029","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonbullous pemphigoid: Insights in clinical and diagnostic findings, treatment responses, and prognosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}